国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2012年
14期
1098-1104
,共7页
慢性阻塞性肺疾病%肺间质纤维化
慢性阻塞性肺疾病%肺間質纖維化
만성조새성폐질병%폐간질섬유화
Chronic obstructive pulmonary diseases%Pulmonary interstitial fibrosis
随着对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)研究的不断深入,COPD后期肺间质纤维化(pulmonary interstitial fibrosis,PIF)的改变逐渐取代了肺气肿的固有变化的现象已经被多位学者证实,并被临床工作者接受,使以往认为COPD与PIF是两种相互独立、不能共存的疾病类型的观点发生改变.双重的病理改变更加严重地破坏了肺组织结构,造成严重缺氧和弥散功能障碍,使COPD病情恶化加速,其发病率及病死率逐年增高,已引起学术界的广泛关注,并对其进行了深入研究,但突破性进展仍有待时日.目前尚存在的瓶颈问题包括病因不清、发病机制复杂、病情多呈进行性进展、临床缺乏早期诊断手段、缺乏有效的治疗措施等,而恰恰早期诊断和恰当的治疗仍可望改善患者的生活质量和延长生存期.本文阐述了COPD合并PIF的发病机制、诊断、治疗方面的研究现状,以深化对COPD合并PIF的认识,为临床提供预防、诊断及抗炎、抗纤维化的治疗思路.
隨著對慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)研究的不斷深入,COPD後期肺間質纖維化(pulmonary interstitial fibrosis,PIF)的改變逐漸取代瞭肺氣腫的固有變化的現象已經被多位學者證實,併被臨床工作者接受,使以往認為COPD與PIF是兩種相互獨立、不能共存的疾病類型的觀點髮生改變.雙重的病理改變更加嚴重地破壞瞭肺組織結構,造成嚴重缺氧和瀰散功能障礙,使COPD病情噁化加速,其髮病率及病死率逐年增高,已引起學術界的廣汎關註,併對其進行瞭深入研究,但突破性進展仍有待時日.目前尚存在的瓶頸問題包括病因不清、髮病機製複雜、病情多呈進行性進展、臨床缺乏早期診斷手段、缺乏有效的治療措施等,而恰恰早期診斷和恰噹的治療仍可望改善患者的生活質量和延長生存期.本文闡述瞭COPD閤併PIF的髮病機製、診斷、治療方麵的研究現狀,以深化對COPD閤併PIF的認識,為臨床提供預防、診斷及抗炎、抗纖維化的治療思路.
수착대만성조새성폐질병(chronic obstructive pulmonary disease,COPD)연구적불단심입,COPD후기폐간질섬유화(pulmonary interstitial fibrosis,PIF)적개변축점취대료폐기종적고유변화적현상이경피다위학자증실,병피림상공작자접수,사이왕인위COPD여PIF시량충상호독립、불능공존적질병류형적관점발생개변.쌍중적병리개변경가엄중지파배료폐조직결구,조성엄중결양화미산공능장애,사COPD병정악화가속,기발병솔급병사솔축년증고,이인기학술계적엄범관주,병대기진행료심입연구,단돌파성진전잉유대시일.목전상존재적병경문제포괄병인불청、발병궤제복잡、병정다정진행성진전、림상결핍조기진단수단、결핍유효적치료조시등,이흡흡조기진단화흡당적치료잉가망개선환자적생활질량화연장생존기.본문천술료COPD합병PIF적발병궤제、진단、치료방면적연구현상,이심화대COPD합병PIF적인식,위림상제공예방、진단급항염、항섬유화적치료사로.
With the further research of chronic obstructive pulmonary diseases (COPD),in the later stage of COPD,not only the phenomena that the changes of pulmonary interstitial fibrosis (PIF) is replacing the innate changes of emophysematous architecture gradually has been confirmed by scholars and accepted by clinicians,but also the view that COPD and PIF are two independent disease types is changing.The double pathological change would further damage the lung tissue,lead to severe hypoxia and dysfunction of diffusion and aggravate the condition of COPD.With the increasing rate of morbidity and mortality,COPD with PIF has been further studied and attracted attentions of academia,but it is still a long way to make breakthrough progress.The current bottleneck problems include unclear cause and pathogenesis,the progressing worsen of conditions,the lack of methods of early diagnosis and efficient therapy and so on.And just the correct early diagnosis and proper therapy may improve the patients' quality of life and prolong their life span.The article reports the current study status of pathogenesis,diagnosis,management of COPD with PIF in order to deepen the cognition of this kind of disease,as well as to provide ideas about its prevention,diagnosis and the therapy of anti-inflammatory and anti-fibrosis for clinic.